Neurosense Therapeutics News - October 13, 2026
🔴 Neurosense Therapeutics is trading 18.3% down in after-hours trading — no specific cause established
Neurosense Therapeutics is trading at $2.85, down 18.34% in after-hours trading; available evidence does not establish a specific cause. - Nasdaq appeal...
NeuroSense Buys Time on Nasdaq, but Can a $13 Million Biotech Close a $35 Million Gap Before the Clock Runs Out?
Shares of NeuroSense Therapeutics surged 13.2% to $3.95 after the company disclosed that a Nasdaq Hearings Panel will review its delisting appeal on November...
🟢 Neurosense Therapeutics is trading 13.2% up in after-hours trading amid Nasdaq appeal update
Neurosense Therapeutics is trading 13.2% up at $3.95 after closing at $3.49 on October 13; the Nasdaq update is a plausible company-specific catalyst, but the...
🟢 Neurosense Therapeutics is trading 6.9% up in after-hours trading — catalyst remains unconfirmed
Neurosense Therapeutics is trading 6.9% higher at $3.73 after hours; the catalyst remains unconfirmed. - It closed at $3.49 on October 13, after...
🟢 Neurosense Therapeutics is trading 10% up today with Nasdaq hearing scheduled for November 10
Neurosense Therapeutics is trading at $3.78, up +9.68%; coverage does not directly tie the gain to a catalyst. - The company announced October 13 that its...